Danaher Corporation $DHR Shares Sold by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC lessened its stake in Danaher Corporation (NYSE:DHR) by 13.1% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,317 shares of the conglomerate’s stock after selling 1,253 shares during the period. Verdence Capital Advisors LLC’s holdings in Danaher were worth $1,643,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in DHR. GAMMA Investing LLC increased its position in Danaher by 22.2% in the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares during the period. Assenagon Asset Management S.A. increased its position in Danaher by 1.0% during the 1st quarter. Assenagon Asset Management S.A. now owns 20,634 shares of the conglomerate’s stock worth $4,230,000 after purchasing an additional 203 shares during the period. NorthCrest Asset Manangement LLC purchased a new position in shares of Danaher during the 1st quarter worth approximately $262,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of Danaher by 4.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 207,169 shares of the conglomerate’s stock worth $42,470,000 after buying an additional 7,907 shares in the last quarter. Finally, Ritholtz Wealth Management raised its stake in shares of Danaher by 8.8% during the 1st quarter. Ritholtz Wealth Management now owns 6,469 shares of the conglomerate’s stock worth $1,326,000 after buying an additional 522 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DHR. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a research note on Friday, July 11th. Guggenheim reissued a “buy” rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Robert W. Baird increased their target price on Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a research note on Friday, July 18th. Rothschild Redb downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Barclays reissued an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $244.60.

Danaher Stock Performance

DHR opened at $205.36 on Tuesday. The stock has a market cap of $147.05 billion, a P/E ratio of 43.69, a P/E/G ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The stock’s 50 day simple moving average is $200.82 and its 200 day simple moving average is $197.06. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is 27.23%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.20% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.